For: | Broquetas T, Carrión JA. Past, present, and future of long-term treatment for hepatitis B virus. World J Gastroenterol 2023; 29(25): 3964-3983 [PMID: 37476586 DOI: 10.3748/wjg.v29.i25.3964] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v29/i25/3964.htm |
Number | Citing Articles |
1 |
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansion. World Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
Abstract(243) |
Core Tip(252) |
Full Article(HTML)(780)
|
Full Article with Cover (PDF)-770K(43)
|
Full Article (Word)-104K(13)
|
Audio-627K(5)
|
Peer-Review Report-197K(33)
|
Answering Reviewers-80K(40)
|
Full Article (PDF)-336K(80)
|
Full Article (XML)-30K(29)
|
Times Cited (1)
|
Total Visits (2084)
|
Open
|
2 |
Yiqi Xiong, Wenying Qiao, Qi Wang, Kang Li, Ronghua Jin, Yonghong Zhang. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1357496
|
3 |
Samuel W. Gillespie, Athreya S. Reddy, Dana M. Burris, S. Hasan Naqvi, Siddappa N. Byrareddy, Christian L. Lorson, Kamal Singh. Islatravir: evaluation of clinical development for HIV and HBV. Expert Opinion on Investigational Drugs 2024; 33(2): 85 doi: 10.1080/13543784.2024.2305130
|
4 |
Fabiola Di Dato, Raffaele Iorio. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?. World Journal of Gastroenterology 2024; 30(17): 2294-2297 doi: 10.3748/wjg.v30.i17.2294
|